Medicinal Product Shortages - update - 15 March 2023

Notice type: Advisory

Date: 15/03/2023

This is the HPRA’s latest weekly update on medicines shortages. We publish this information each week to keep patients and healthcare professionals informed of current and resolved shortages.

We recognise that medicine shortages can be challenging for those who rely on medicines for their health and well-being. It is the case that for many medicines supplied in Ireland, there is more than one strength, form, pack size or brand available from different suppliers.

Your doctor or pharmacist will often be able to supply an alternative strength, form or product to ensure continuity of treatment if the medicine you have been taking is unavailable.

Resolved shortages

The following shortages have been resolved and supply has resumed to the Irish market:

Product

 

Active Ingredient(s)

Clonazepam Rosemont 0.5mg/5ml Oral Solution

PA23081/009/001

Taw Pharma (Ireland) Ltd

Clonazepam

Dermovate 0.05% w/w Cream

PA1077/005/001

GlaxoSmithKline (Ireland) Limited

Clobetasol

Dermovate 0.05%w/w Ointment

PA1077/005/002

GlaxoSmithKline (Ireland) Limited

Clobetasol

Diovan 320mg Film Coated Tablets

PA0896/009/004

Novartis Ireland Limited

Valsartan

Epanutin Ready Mixed Parenteral 250mg/5ml Solution for Injection or Infusion

PA23055/003/006

Upjohn EESV

Phenytoin sodium

Lercanidipine Clonmel 10mg Film Coated Tablets

PA0126/187/001

Clonmel Healthcare Ltd

Lercanidipine

Lyrica 100mg Hard Capsules

EU/1/04/279/015

Upjohn EESV

Pregabalin

Nolpaza 40mg Gastro Resistant Tablets

PA1347/006/002

KRKA, d.d., Novo mesto

Pantoprazole

Primacine 250mg/5ml Granules for Oral Suspension

PA0281/026/008

Pinewood Laboratories Ltd

Erythromycin

Visudyne Powder for Solution for Infusion

EU/1/00/140/001

CHEPLAPHARM Arzneimittel GmbH

Verteporfin

Triapin 2.5mg/2.5mg Prolonged Release Tablet

PA0540/082/001

Sanofi-Aventis Ireland Limited T/A SANOFI

Felodipine & ramipril

 

Newly notified shortages

The HPRA has been notified of a shortage of the following products:

Product

 

Active Ingredient(s)

Alka-Seltzer Effervescent Tablets

PA1410/032/001

Bayer Limited

Sodium hydrogen carbonate, aspirin & citric acid

Canesten Combi Pessary & Cream

PA1410/039/001

Bayer Limited

Clotrimazole

Dalmane 15mg Hard Capsules

PA2010/039/001

Mylan IRE Healthcare Limited

Flurazepam

Doxane XL 4mg Prolonged Release Tablets

PA0711/103/001

Rowex Ltd

Doxazosin

Heparin Sodium BP 2000 IU/l in 0.9 % w/v Sodium Chloride IV infusion

PA2299/014/002

Baxter Holding B.V.

Heparin, Citric acid, disodium phosphate dodecahydrate & sodium chloride

Januvia 50mg Film Coated Tablets

EU/1/07/383/008

Merck Sharp and Dohme B.V

Sitagliptin

Metformin Aurobindo 1000mg Film Coated Tablets

PA1445/021/003

Aurobindo Pharma (Malta) Limited

Metformin

Migraleve Film Coated Tablets

PA0330/030/003

Johnson & Johnson (Ireland) Limited

Buclizine, paracetamol & codeine

Olmesartan Rowex 10mg Tablets

PA0711/255/001

Rowex Ltd

Olmesartan

Prednisolone 5mg Soluble Tablets

PA1142/034/001

Amdipharm Limited

Prednisolone

Please see the shortages section of the HPRA website for further information

The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.

 



« Back